Robinhood (HOOD) took a steep dive after reporting its fourth-quarter revenue that fell short of Wall Street expectations, rattling investor confidence despite a year marked by record overall sales. ...
Hims & Hers (HIMS) took a steep dive after U.S. regulators signaled an aggressive move against compounded versions of blockbuster weight-loss medicines, shaking investor confidence in one of the fastest-growing ...
Shares of Advanced Micro Devices (AMD) took a steep dive on Wednesday despite the fact that the chipmaker delivered a solid fourth-quarter earnings beat, demonstrating how unforgiving markets have become ...
SanDisk’s historic run is still taking off. Shares surged once again after the company issued earnings guidance that crushed Wall Street forecasts, extending a rally that now totals roughly 1,600% ...
Oracle’s shares have fallen more than 50% from its 2025 high, wiping out hundreds of billions of dollars in market value as investor enthusiasm around AI gives way to tougher ...
Shares of UnitedHealth Group (UNH) took a dive on Tuesday, leading a broad selloff across the health insurance sector after the Trump administration announced a surprise proposal that limits future ...
CoreWeave (CRWV) surged on Monday after Nvidia committed an additional $2 billion to the fast-growing AI cloud provider, reinforcing the company’s position at the center of the global race to ...
Intel (INTC) experienced a steep sell-off on Friday after the chipmaker delivered first-quarter guidance that fell short of Wall Street expectations, fueling worries about whether its long-promised turnaround can gain ...
Intel has had a solid start to 2026, as investors grow more confident that the chipmaker’s long-running turnaround is finally gaining traction. ...
Chip stocks surged on Thursday after Taiwan Semiconductor Manufacturing (TSMC) delivered results and guidance that reignited confidence in the resilience of the AI boom, pushing back against rising fears that ...
Intel (INTC) shares popped on Tuesday after a major Wall Street upgrade highlighted growing confidence in the chipmaker’s turnaround, driven by surging data center demand tied to AI and meaningful ...
Amneal Pharmaceuticals (AMRX) has entered 2026 with powerful momentum after a year that reshaped investor sentiment around the stock. ...